179 related articles for article (PubMed ID: 26311050)
1. PEBP4 promoted the growth and migration of cancer cells in pancreatic ductal adenocarcinoma.
Zhang D; Dai Y; Cai Y; Suo T; Liu H; Wang Y; Cheng Z; Liu H
Tumour Biol; 2016 Feb; 37(2):1699-705. PubMed ID: 26311050
[TBL] [Abstract][Full Text] [Related]
2. FOXC2 is up-regulated in pancreatic ductal adenocarcinoma and promotes the growth and migration of cancer cells.
Cui L; Dang S; Qu J; Mao Z; Wang X; Zhang J; Chen J
Tumour Biol; 2016 Jul; 37(7):8579-85. PubMed ID: 26733175
[TBL] [Abstract][Full Text] [Related]
3. Activation of vitamin D receptor signaling downregulates the expression of nuclear FOXM1 protein and suppresses pancreatic cancer cell stemness.
Li Z; Jia Z; Gao Y; Xie D; Wei D; Cui J; Mishra L; Huang S; Zhang Y; Xie K
Clin Cancer Res; 2015 Feb; 21(4):844-53. PubMed ID: 25501129
[TBL] [Abstract][Full Text] [Related]
4. The Novel KLF4/MSI2 Signaling Pathway Regulates Growth and Metastasis of Pancreatic Cancer.
Guo K; Cui J; Quan M; Xie D; Jia Z; Wei D; Wang L; Gao Y; Ma Q; Xie K
Clin Cancer Res; 2017 Feb; 23(3):687-696. PubMed ID: 27449499
[TBL] [Abstract][Full Text] [Related]
5. MTA2-mediated inhibition of PTEN leads to pancreatic ductal adenocarcinoma carcinogenicity.
Si W; Liu X; Wei R; Zhang Y; Zhao Y; Cui L; Hong T
Cell Death Dis; 2019 Feb; 10(3):206. PubMed ID: 30814496
[TBL] [Abstract][Full Text] [Related]
6. SIRT 1 Overexpression is Associated with Metastasis of Pancreatic Ductal Adenocarcinoma (PDAC) and Promotes Migration and Growth of PDAC Cells.
Li S; Hong H; Lv H; Wu G; Wang Z
Med Sci Monit; 2016 May; 22():1593-600. PubMed ID: 27170223
[TBL] [Abstract][Full Text] [Related]
7. Overexpressed EDIL3 predicts poor prognosis and promotes anchorage-independent tumor growth in human pancreatic cancer.
Jiang SH; Wang Y; Yang JY; Li J; Feng MX; Wang YH; Yang XM; He P; Tian GA; Zhang XX; Li Q; Cao XY; Huo YM; Yang MW; Fu XL; Li J; Liu DJ; Dai M; Wen SY; Gu JR; Hong J; Hua R; Zhang ZG; Sun YW
Oncotarget; 2016 Jan; 7(4):4226-40. PubMed ID: 26735172
[TBL] [Abstract][Full Text] [Related]
8. Tumor-neuroglia interaction promotes pancreatic cancer metastasis.
Su D; Guo X; Huang L; Ye H; Li Z; Lin L; Chen R; Zhou Q
Theranostics; 2020; 10(11):5029-5047. PubMed ID: 32308766
[No Abstract] [Full Text] [Related]
9. Ribonucleoprotein HNRNPA2B1 interacts with and regulates oncogenic KRAS in pancreatic ductal adenocarcinoma cells.
Barceló C; Etchin J; Mansour MR; Sanda T; Ginesta MM; Sanchez-Arévalo Lobo VJ; Real FX; Capellà G; Estanyol JM; Jaumot M; Look AT; Agell N
Gastroenterology; 2014 Oct; 147(4):882-892.e8. PubMed ID: 24998203
[TBL] [Abstract][Full Text] [Related]
10. CCDC88A, a prognostic factor for human pancreatic cancers, promotes the motility and invasiveness of pancreatic cancer cells.
Tanouchi A; Taniuchi K; Furihata M; Naganuma S; Dabanaka K; Kimura M; Watanabe R; Kohsaki T; Shimizu T; Saito M; Hanazaki K; Saibara T
J Exp Clin Cancer Res; 2016 Dec; 35(1):190. PubMed ID: 27919290
[TBL] [Abstract][Full Text] [Related]
11. Lysine demethylase 2 (KDM2B) regulates hippo pathway via MOB1 to promote pancreatic ductal adenocarcinoma (PDAC) progression.
Quan M; Chen Z; Jiao F; Xiao X; Xia Q; Chen J; Chao Q; Li Y; Gao Y; Yang H; Wang L; Cui J
J Exp Clin Cancer Res; 2020 Jan; 39(1):13. PubMed ID: 31941533
[TBL] [Abstract][Full Text] [Related]
12. Role of the PEBP4 protein in the development and metastasis of gastric cancer.
Wu Z; Liu B; Zheng X; Hou H; Li Y
Oncotarget; 2017 Mar; 8(11):18177-18184. PubMed ID: 28193908
[TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA CUDR promotes malignant phenotypes in pancreatic ductal adenocarcinoma via activating AKT and ERK signaling pathways.
Liang X; Qi M; Wu R; Liu A; Chen D; Tang L; Chen J; Hu X; Li W; Zhan L; Shao C
Int J Oncol; 2018 Dec; 53(6):2671-2682. PubMed ID: 30272271
[TBL] [Abstract][Full Text] [Related]
14. LRG-1 promotes pancreatic cancer growth and metastasis via modulation of the EGFR/p38 signaling.
Xie ZB; Zhang YF; Jin C; Mao YS; Fu DL
J Exp Clin Cancer Res; 2019 Feb; 38(1):75. PubMed ID: 30760292
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of PD2 leads to increased tumorigenicity and metastasis in pancreatic ductal adenocarcinoma.
Vaz AP; Deb S; Rachagani S; Dey P; Muniyan S; Lakshmanan I; Karmakar S; Smith L; Johansson S; Lele S; Ouellette M; Ponnusamy MP; Batra SK
Oncotarget; 2016 Jan; 7(3):3317-31. PubMed ID: 26689992
[TBL] [Abstract][Full Text] [Related]
16. hERG1 channels drive tumour malignancy and may serve as prognostic factor in pancreatic ductal adenocarcinoma.
Lastraioli E; Perrone G; Sette A; Fiore A; Crociani O; Manoli S; D'Amico M; Masselli M; Iorio J; Callea M; Borzomati D; Nappo G; Bartolozzi F; Santini D; Bencini L; Farsi M; Boni L; Di Costanzo F; Schwab A; Onetti Muda A; Coppola R; Arcangeli A
Br J Cancer; 2015 Mar; 112(6):1076-87. PubMed ID: 25719829
[TBL] [Abstract][Full Text] [Related]
17. The multifunctional growth factor midkine promotes proliferation and migration in pancreatic cancer.
Rawnaq T; Dietrich L; Wolters-Eisfeld G; Uzunoglu FG; Vashist YK; Bachmann K; Simon R; Izbicki JR; Bockhorn M; Güngör C
Mol Cancer Res; 2014 May; 12(5):670-80. PubMed ID: 24567526
[TBL] [Abstract][Full Text] [Related]
18. DJ-1 promotes invasion and metastasis of pancreatic cancer cells by activating SRC/ERK/uPA.
He X; Zheng Z; Li J; Ben Q; Liu J; Zhang J; Ji J; Yu B; Chen X; Su L; Zhou L; Liu B; Yuan Y
Carcinogenesis; 2012 Mar; 33(3):555-62. PubMed ID: 22223849
[TBL] [Abstract][Full Text] [Related]
19. RACK1 overexpression associates with pancreatic ductal adenocarcinoma growth and poor prognosis.
Li X; Xiao Y; Fan S; Xiao M; Wang X; Chen X; Li C; Zong G; Zhou G; Wan C
Exp Mol Pathol; 2016 Oct; 101(2):176-186. PubMed ID: 27498047
[TBL] [Abstract][Full Text] [Related]
20. Hyaluronan stimulates pancreatic cancer cell motility.
Cheng XB; Kohi S; Koga A; Hirata K; Sato N
Oncotarget; 2016 Jan; 7(4):4829-40. PubMed ID: 26684359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
